Pharma channel feed

Au­robindo Phar­ma re­ceives warn­ing let­ter from In­di­a's SEC fol­low­ing more FDA ques­tion marks

3 years ago
FDA+
Manufacturing

Eu­rope to buy 110k dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine — as EU-li­censed vac­cine not eas­i­ly ac­ces­si­ble

3 years ago

CVS re­sumes cov­er­age of block­buster blood thin­ner af­ter price drop fol­lows Jan­u­ary ex­clu­sion

3 years ago

#Can­nes­Lions2022: Con­sumer health ex­ecs call on agen­cies to in­volve pa­tients in cre­ative process

3 years ago
Marketing

#Can­nes­Lions2022: Phar­ma and health mar­keters lose spot­light at cre­ativ­i­ty ad fest, but does it mat­ter?

3 years ago
Marketing

#Can­nes­Lions2022: Di­ver­si­ty, eq­ui­ty and in­clu­sion takes cen­ter stage as phar­ma in­dus­try is called to ac­tion

3 years ago
Marketing

Spero’s UTI can­di­date gets the CRL ham­mer as the com­pa­ny falls in­to pen­ny stock sta­tus

3 years ago
FDA+

A decade af­ter its first ap­proval, FDA ex­pands weight loss pil­l's la­bel for use in ado­les­cents

3 years ago

Four months af­ter CRL due to con­t­a­m­i­nant wor­ries, Gilead re­turns to FDA for next-gen HIV drug

3 years ago
R&D

Scoop: Roche scraps one of two schiz­o­phre­nia PhII tri­als af­ter fail­ing the pri­ma­ry end­point

3 years ago
R&D

How pre­pared is bio­phar­ma for the cy­ber dooms­day?

3 years ago
In Focus

Alex­ion puts €65M for­ward to strength­en its po­si­tion on the Emer­ald Isle

3 years ago
Financing
Manufacturing

Am­gen takes next step with its Chi­na am­bi­tions, out-li­cens­ing drugs to Fo­s­un Phar­ma

3 years ago
China

As court case looms, Bris­tol My­ers touts la­bel ex­pan­sion for Breyanzi

3 years ago
Cell/Gene Tx
FDA+

Fed­er­al judge de­nies Bris­tol My­er­s' at­tempt to avoid Cel­gene share­hold­er law­suit

3 years ago
Law

Capri­cor hits pri­ma­ry end­point in Duchenne ex­ten­sion study, ready­ing its FDA pitch

3 years ago
Cell/Gene Tx

De­spite a slow start to the year for deals, PwC pre­dicts a flur­ry of ac­tiv­i­ty com­ing up

3 years ago

Am­ryt Phar­ma sub­mits a for­mal dis­pute res­o­lu­tion to the FDA over re­ject­ed skin dis­ease drug

3 years ago
FDA+

Phar­ma-friend­ly sen­a­tor calls on FDA for a third time to show patent pro­tec­tions should­n't be blamed for high drug prices

3 years ago
FDA+

New re­port de­tails se­quence of events lead­ing up to death of man who re­ceived pig heart trans­plant

3 years ago
R&D

EMA signs off on 3 drugs re­cent­ly re­ject­ed by FDA, in­clud­ing Bio­Mar­in's new he­mo­phil­ia gene ther­a­py

3 years ago
FDA+

Joe Pa­pa re­signs as chair of Bausch Health as bil­lion­aire John Paul­son takes over

3 years ago
People

Bear mar­ket hits an­oth­er biotech as Red­Hill Bio­phar­ma lays off a third of US sales­force

3 years ago
People

CD­C's ACIP rec­om­mends high­er dose, Se­qirus, Sanofi flu vac­cines in adults 65 and old­er

3 years ago
First page Previous page 191192193194195196197 Next page Last page
A service from the Financial Times